Guru Ownership Trend
Guru Analysis for Fate Therapeutics, Inc. (FATE)
Fate Therapeutics, Inc. (FATE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.72 M.
Top institutional holders include Renaissance Technologies and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $2.06 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies who increased their stake by 488.7%.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 0.00% | Add 488.7% | 1,262,515 | $1.59 M | Q3 2025 | |
| 0.00% | Add 33.7% | 1,131,414 | $1.43 M | Q3 2025 | |
| 0.28% | Add 69.9% | 729,188 | $918,777 | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Fate Therapeutics, Inc. (FATE)
Major holders include Renaissance Technologies ($1.59 M), Cliff Asness ($1.43 M), Robert Bruce ($918,777). According to the latest reported data, 3 tracked investment managers collectively hold approximately 3.12 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.06 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in FATE during the most recent reporting period.
Yes, 0 managers opened new positions in FATE, and 3 increased their existing holdings. The total reported buy value was $2.06 M.